These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 6703827)
21. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group]. Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V; Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268 [TBL] [Abstract][Full Text] [Related]
22. Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma. Haselkorn T; Fish JE; Chipps BE; Miller DP; Chen H; Weiss ST Respir Med; 2009 Feb; 103(2):274-83. PubMed ID: 18819787 [TBL] [Abstract][Full Text] [Related]
23. Flunking asthma? When HEDIS takes the ACT. Lim KG; Patel AM; Naessens JM; Li JT; Volcheck GW; Wagie AE; Enders FB; Beebe TJ Am J Manag Care; 2008 Aug; 14(8):487-94. PubMed ID: 18690764 [TBL] [Abstract][Full Text] [Related]
24. Some indications for depot methylprednisolone for asthma or other severe allergic disease. Patterson R; Greenberger PA; Grammer LC J Allergy Clin Immunol; 1986 May; 77(5):686-9. PubMed ID: 3700892 [TBL] [Abstract][Full Text] [Related]
25. Compliance and the rehabilitation alliance. Aquila R; Weiden PJ; Emanuel M J Clin Psychiatry; 1999; 60 Suppl 19():23-7; discussion 28-9. PubMed ID: 10507277 [TBL] [Abstract][Full Text] [Related]
26. Time required to achieve asthma control in not previously inhaled corticosteroid treated adult patients. Ramos Costa Mdo R; de Oliveira MA; Caetano LB; Santoro IL; Godoy Fernandes AL J Asthma; 2008 Sep; 45(7):579-82. PubMed ID: 18773330 [TBL] [Abstract][Full Text] [Related]
28. [Efficiency of methotrexate in the treatment of cortico-dependent asthmatic patients]. Domingo Ribas C; Comet Monte R; Bosque García M; Morón Besolí A; Montón Soler C Rev Clin Esp; 1999 Mar; 199(3):142-6. PubMed ID: 10230292 [TBL] [Abstract][Full Text] [Related]
29. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
30. [Compliance of children with bronchial asthma in long-term therapy with theophylline retard preparations]. Köhler E; Sollich V; Schuster R Kinderarztl Prax; 1993 Aug; 61(6):207-10. PubMed ID: 8411846 [TBL] [Abstract][Full Text] [Related]
31. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. Duncan JC; Rogers R J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389 [TBL] [Abstract][Full Text] [Related]
32. Factors affecting patients' compliance to metered-dose inhaler drugs in two asthma clinics in Tehran, Iran. Tavasoli S; Heidarnazhad H; Kazemnejad A Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):187-93. PubMed ID: 17237572 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538 [TBL] [Abstract][Full Text] [Related]
34. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. Charles T; Quinn D; Weatherall M; Aldington S; Beasley R; Holt S J Allergy Clin Immunol; 2007 Apr; 119(4):811-6. PubMed ID: 17320942 [TBL] [Abstract][Full Text] [Related]
35. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732 [TBL] [Abstract][Full Text] [Related]
36. Compliance differences following administration of theophylline at six- and twelve-hour intervals. Tinkelman DG; Vanderpool GE; Carroll MS; Page EG; Spangler DL Ann Allergy; 1980 May; 44(5):283-6. PubMed ID: 7377640 [TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of Kenalog 40 in treating bronchial asthma with hormonal dependence]. Molotkov VN; Sil'vestrov VP; Iashina LA Vrach Delo; 1980 Apr; (4):14-6. PubMed ID: 6992448 [No Abstract] [Full Text] [Related]
38. [Compliance in asthma patients]. Khadraoui M; Cheikh R; Ben Mustapha MA; Zaibi M; Zribi S; Haffani F; Ben Hassine K Tunis Med; 1989 Oct; 67(10):625-30. PubMed ID: 2815353 [No Abstract] [Full Text] [Related]
39. [Therapy of bronchial asthma with synthetic delayed-action corticotropin]. Andersson E; Lorenzen J Nord Med; 1968 Aug; 80(32):1050-2. PubMed ID: 4301738 [No Abstract] [Full Text] [Related]
40. Noncompliance and prevarication in life threatening adolescent asthma. Chandler MJ; Grammer LC; Patterson R N Engl Reg Allergy Proc; 1986; 7(4):367-70. PubMed ID: 3475551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]